Dual‐Site‐Binding Ligand‐Driven (100) Orientation for Efficient and Stable Perovskite Solar Cells
Advanced Materials · 2026-08 · 38 (46)
DOI: 10.1002/adma.74033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 09.07.2026. Verfasst von Dongyang Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Mechanics and Control of Mechanical Structures, Institute For Frontier Science, Nanjing University of Aeronautics and Astrona…. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Basic Research Program of Jiangsu Province, State Key Laboratory of Mechanics and Control for Aerospace Structures.
Abstract (Originalsprache)
Regulating crystal orientation is a powerful strategy for enhancing the optoelectronic performance of perovskite solar cells (PSCs). However, most existing approaches rely on single‐site ligand binding, which not only forms insulating layers that hinder charge transport but also involves weak coordination that limits orientation control. Here, we report a holistic strategy based on a dual‐site‐binding ligand, dithiopyr, that simultaneously modulates nucleation kinetics, crystal orientation, defect passivation, and charge transport in perovskite films. By coordinating its dual thioester functionalities with adjacent Pb 2+ defect sites, dithiopyr effectively relieves lattice strain and promotes a preferential (100) orientation, thereby facilitating efficient charge transport. As a result, the inverted PSCs achieve power conversion efficiencies of 26.90% (certified 26.14%) (1.55 eV), 22.02% (1.25 eV), and 23.11% (1.68 eV), respectively. Notably, large‐area modules (30 × 30 cm 2 ) deliver an efficiency of 21.28%, which is among the highest values reported for inverted perovskite solar cells. Unencapsulated devices retain 93.1% of their initial efficiency after 3600 h under ambient conditions and maintain over 95% of their initial performance after 1100 h of maximum power point tracking. This work establishes dithiopyr as a versatile and robust platform for precise crystal orientation control toward high‐performance perovskite photovoltaics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Mechanics and Control of Mechanical Structures, Institute For Frontier Science, Nanjing University of Aeronautics and Astronautics, Nanjing, P.R. China.
- School of Materials Science and Engineering, Shaanxi University of Science and Technology, Xi'an, P.R. China.
- Shanghai Sheng Jian Technology Co., Ltd, Shanghai, P.R. China.
- Key Laboratory of Energy Low-Carbon Conversion and Storage, Jiangxi University of Water Resources and Electric Power, Nanchang, 330099, PR China.
ORCID-Profile: Riming Nie
Förderung
- National Natural Science Foundation of China
- Basic Research Program of Jiangsu Province
- State Key Laboratory of Mechanics and Control for Aerospace Structures
- Prospective Layout of Scientific Research for NUAA
- Open Project Program of Key Laboratory of Energy Low-Carbon Conversion and Storage
- Jiangxi Provincial Department of Education
- Jiangxi University of Water Resources and Electric Power
- Natural Science foundation of Jiangxi Province
Zitieren
APA
Lv, D., Wang, C., Li, L., Chu, W., Ba, Q., Xia, X., & Nie, R. (2026). Dual‐Site‐Binding Ligand‐Driven (100) Orientation for Efficient and Stable Perovskite Solar Cells. Advanced Materials, 38(46). https://doi.org/10.1002/adma.74033
Vancouver
Lv D, Wang C, Li L, Chu W, Ba Q, Xia X, et al. Dual‐Site‐Binding Ligand‐Driven (100) Orientation for Efficient and Stable Perovskite Solar Cells. Advanced Materials. 2026;38(46). doi:10.1002/adma.74033
BibTeX
@article{Lv2026,
author = {Lv, Dongyang and Wang, Cheng and Li, Luyao and Chu, Weicun and Ba, Qiankai and Xia, Xuefeng and Nie, Riming},
title = {Dual‐Site‐Binding Ligand‐Driven (100) Orientation for Efficient and Stable Perovskite Solar Cells},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {46},
doi = {10.1002/adma.74033}
}
EUVIMED